{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:52:51Z","timestamp":1768809171523,"version":"3.49.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["K\/DSC\/001955"],"award-info":[{"award-number":["K\/DSC\/001955"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","award":["19\/2015"],"award-info":[{"award-number":["19\/2015"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0165495","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T13:53:41Z","timestamp":1477576421000},"page":"e0165495","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats"],"prefix":"10.1371","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-9515","authenticated-orcid":true,"given":"Karolina","family":"Pytka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Knutelska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Jakubczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Waszkielewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kota\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.4088\/JCP.v64n1209","article-title":"Increased cholesterol levels during paroxetine administration in healthy men","volume":"64","author":"N Lara","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0895-4356(96)00385-X","article-title":"Risk of syncope in the elderly and consumption of drugs: a case-control study","volume":"50","author":"P Cherin","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2337\/db08-0236","article-title":"Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals","volume":"57","author":"VJ Briscoe","year":"2008","journal-title":"Diabetes"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpeds.2015.10.065","article-title":"Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome","volume":"169","author":"MA Conrad","year":"2016","journal-title":"J Pediatr. Elsevier"},{"key":"ref5","article-title":"Acute liver injury secondary to sertraline","volume":"2013","author":"CFDLW Suen","year":"2013","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10620-008-0524-3","article-title":"Sertraline hepatotoxicity: report of a case and review of the literature","volume":"54","author":"F Tabak","year":"2009","journal-title":"Dig Dis Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e0142499","DOI":"10.1371\/journal.pone.0142499","article-title":"Antidepressant- and anxiolytic-like effects of new dual 5-HT1A and 5-HT7 antagonists in animal models","volume":"10","author":"K Pytka","year":"2015","journal-title":"PLoS ONE"},{"key":"ref8","first-page":"48","article-title":"Chemically Homogenous Compounds with Antagonistic Properties at All \u03b11-Adrenoceptor Subtypes but not \u03b21-Adrenoceptor Attenuate Adrenaline-Induced Arrhythmia in Rats","volume":"7","author":"K Pytka","year":"2016","journal-title":"Front Pharmacol. Frontiers"},{"key":"ref9","first-page":"1","article-title":"Guide for the Care and Use of Laboratory Animals, 8th edition","year":"2010"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cbdd.12394","article-title":"Synthesis and evaluation of antidepressant-like activity of some 4-substituted 1-(2-methoxyphenyl)piperazine derivatives","volume":"85","author":"AM Waszkielewicz","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejphar.2016.02.047","article-title":"Pyrrolidin-2-one derivatives may reduce body weight in rats with diet-induced obesity","volume":"776","author":"M Dudek","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"IF Benzie","year":"1996","journal-title":"Anal Biochem. Academic Press"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"J Sedlak","year":"1968","journal-title":"Anal Biochem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e0147238","DOI":"10.1371\/journal.pone.0147238","article-title":"Cysteine Metabolism and Oxidative Processes in the Rat Liver and Kidney after Acute and Repeated Cocaine Treatment","volume":"11","author":"D Kowalczyk-Pachel","year":"2016","journal-title":"PLoS ONE. Public Library of Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s13197-011-0251-1","article-title":"Genesis and development of DPPH method of antioxidant assay","volume":"48","author":"SB Kedare","year":"2011","journal-title":"J Food Sci Technol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pbb.2015.03.019","article-title":"Antinociceptive, anti-inflammatory and smooth muscle relaxant activities of the pyrrolo[3,4-d]pyridazinone derivatives: Possible mechanisms of action","volume":"133","author":"S Mogilski","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1476-5381.1959.tb00928.x","article-title":"Some quantitative uses of drug antagonists","volume":"14","author":"O Arunlakshana","year":"1959","journal-title":"British Journal of Pharmacology and Chemotherapy"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"P Pacher","year":"2004","journal-title":"Curr Pharm Des"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0024-3205(79)90466-1","article-title":"Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats","volume":"25","author":"RW Fuller","year":"1979","journal-title":"Life Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14740338.5.4.523","article-title":"The effect of antidepressants on lipid homeostasis: a cardiac safety concern?","volume":"5","author":"RS McIntyre","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.jcp.0000138762.23482.63","article-title":"Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment","volume":"24","author":"D Kopf","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","article-title":"Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments","volume":"64","author":"M Bilici","year":"2001","journal-title":"Journal of Affective Disorders"},{"key":"ref23","first-page":"145","article-title":"Metabolic and physiologic consequences of nortriptyline treatment in the elderly","volume":"30","author":"BG Pollock","year":"1994","journal-title":"Psychopharmacol Bull"},{"key":"ref24","first-page":"352","article-title":"Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study","volume":"187","author":"J Bradwejn","year":"2005","journal-title":"Br J Psychiatry. The Royal College of Psychiatrists"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-1781(90)90089-N","article-title":"Increased serum total cholesterol to HDL-cholesterol ratio after imipramine","volume":"32","author":"VK Yeragani","year":"1990","journal-title":"Psychiatry Res"},{"key":"ref26","first-page":"633","article-title":"Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial","volume":"10","author":"JW Anderson","year":"2002","journal-title":"Obes Res. Blackwell Publishing Ltd"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/0253-7176.130968","article-title":"A controlled study of serum lipid profiles in Indian patients with depressive episode","volume":"36","author":"BN Patra","year":"2014","journal-title":"Indian J Psychol Med. Medknow Publications"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.mehy.2009.11.041","article-title":"Is the increase in LDL cholesterol induced by selective serotonin reuptake inhibitor therapy a blessing in disguise?","volume":"74","author":"MR Goldstein","year":"2010","journal-title":"Med Hypotheses. Elsevier Ltd"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12529-013-9358-2","article-title":"Association between lipid profile and depressive symptoms among Chinese older people: mediation by cardiovascular diseases?","volume":"21","author":"Y Liang","year":"2014","journal-title":"Int J Behav Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and type 2 diabetes over the lifespan: a meta-analysis","volume":"31","author":"B Mezuk","year":"2008","journal-title":"Diabetes Care"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00125-006-0159-x","article-title":"Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis","volume":"49","author":"MJ Knol","year":"2006","journal-title":"Diabetologia"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.2174\/138161212803523662","article-title":"Glucose metabolism and antidepressant medication","volume":"18","author":"JM Hennings","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1211\/0022357991772899","article-title":"Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice","volume":"51","author":"A Erenmemisoglu","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"ref34","first-page":"65","article-title":"Effect of acute & chronic imipramine treatment on glucose homeostasis","volume":"96","author":"B Gupta","year":"1992","journal-title":"Indian J Med Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","article-title":"Antidepressant-induced liver injury: a review for clinicians","volume":"171","author":"CS Voican","year":"2014","journal-title":"Am J Psychiatry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jcph.662","article-title":"Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms","volume":"56","author":"M Gahr","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"HHJ Gerets","year":"2012","journal-title":"Cell Biol Toxicol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0165495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:26:14Z","timestamp":1540250774000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0165495"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,27]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0165495","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,27]]}}}